FK506 attenuates 1-methyl-4-phenylpyridinium- and 3-nitropropionic acid-evoked inhibition of kynurenic acid synthesis in rat cortical slices

Acta Neurobiologiae Experimentalis

Volumn 63, Issue 2, 2003, Pages 101-108

  Luchowska, Elzbieta ^a   Luchowski, Piotr ^a   Wielosz, Marian ^a   Turski, Waldemar A ^a,b   Urbanska, Ewa M ^a,b  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

Author keywords

1 methyl 4 phenylpyridinium; 3 nitropropionic acid; Cyclosporin A; Dantrolene; FK506; In vitro; Kynurenic acid; Mitochondrial inhibitors

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 3 NITROPROPIONIC ACID; CYCLOSPORIN A; DANTROLENE; KYNURENIC ACID; KYNURENINE AMINOTRANSFERASE; TACROLIMUS;

ANIMAL TISSUE; BRAIN CORTEX; BRAIN TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; ENERGY; ENZYME ACTIVITY; MALE; METABOLISM; MITOCHONDRION; NERVE DEGENERATION; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; RAT; SYNTHESIS;

1-METHYL-4-PHENYLPYRIDINIUM; ANIMALS; CEREBRAL CORTEX; CONVULSANTS; CYCLOSPORINE; DANTROLENE; DRUG INTERACTIONS; EXCITATORY AMINO ACID ANTAGONISTS; HERBICIDES; IMMUNOSUPPRESSIVE AGENTS; KYNURENIC ACID; MALE; MITOCHONDRIA; MUSCLE RELAXANTS, CENTRAL; NITRO COMPOUNDS; ORGAN CULTURE TECHNIQUES; PROPIONIC ACIDS; RATS; RATS, WISTAR; TACROLIMUS;

EID: 0038317702     PISSN: 00651400     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (35)

1. Beal M.F., Brouillet E., Jenkins B.G., Ferrante R.J., Kowall N.W., Miller J.M., Storey E., Srivastava R., Rosen B.R., Hyman B.T. (1993) Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci 13: 4181-4192.
2. Bloem B.R., Irwin I., Buruma O.J., Haan J., Roos R.A., Tetrud J.W., Langston J.W. (1990) The MPTP model: versatile contributions to the treatment of idiopathic Parkinson's disease. J Neurol Sci 97: 273-293.
3. Bochelen D., Rudin M., Sauter A. (1999) Calcineurin inhibitors, FK506 and SDZ ASM 981, alleviate the outcome of focal cerebral ischemic/reperfusion injury. J Pharmacol Exp Ther 288: 653-659.
4. Borlongan C.V., Koutouzis T.K., Freeman T.B., Cahill D.W., Sanberg P.R. (1995) Behavioral pathology induced by repeated systemic injections of 3-nitropropionic acid mimics the motoric symptoms of Huntington's disease. Brain Res 697: 254-257.
5. Brouillet E., Guyot M.C., Mittoux V., Altairac S., Conde F., Palfi S., Hantraye P. (1998) Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat. J Neurochem 70: 794-805.
6. 2+ homeostasis. J Neurochem 66: 403-411.
7. Burns R.S., Chiueh C.C., Markey S.P., Ebert M.H., Jacobowitz D.M., Kopin I.J. (1983) A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci U S A 80: 4546-4550.
8. Gepdiremen A., Duzenli S., Hacimuftuoglu A., Suleyman H., Oztas S. (2001) The effects of dantrolene alone or on combination with nimodipine in glutamate-induced neurotoxicity in cerebellar granular cell cultures of rat pups. Pharmacol Res 43: 241-244.
9. Gold B.G. (2000) Neuroimmunophilin ligands: evaluation of their therapeutic potential for the treatment of neurological disorders. Expert Opin Investig Drugs 9: 2331-2342.
10. Guidetti P., Okuno E., Schwarcz R. (1997) Characterization of rat brain kynurenine aminotransferases I and II. J Neurosci Res 50: 457-465.
11. Guo X., Dillman J.F. 3rd, Dawson V.L., Dawson T.M. (2001) Neuroimmunophilins: novel neuroprotective and neuroregenerative targets. Ann Neurol 50: 6-16.
12. He L., Lemasters J.J. (2002) Regulated and unregulated mitochondrial permeability transition pores: a new paradigm of pore structure and function? FEBS Lett 512: 1-7.
13. Heiman-Patterson T.D. (1993) Neuroleptic malignant syndrome and malignant hyperthermia. Important issues for the medical consultant. Med Clin North Am 77: 477-492.
14. Hilmas C., Pereira E.F., Alkondon M., Rassoulpour A., Schwarcz R., Albuquerque E.X. (2001) The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications. J Neurosci 21: 7463-7473.
15. Hodgkins P.S., Wu H.Q., Zielke H.R., Schwarcz R. (1999) 2-oxoacids regulate kynurenic acid production in the rat brain: studies in vitro and in vivo. J Neurochem 72: 643-651.
16. Kaibori M., Inoue T., Tu W., Oda M., Kwon A.H., Kamiyama Y., Okumura T. (2001) FK506, but not cyclosporin A, prevents mitochondrial dysfunction during hypoxia in rat hepatocytes. Life Sci 69: 17-26.
17. Kikuchi M., Kashii S., Mandai M., Yasuyoshi H., Honda Y., Kaneda K., Akaike A. (1998) Protective effects of FK506 against glutamate-induced neurotoxicity in retinal cell culture. Invest Ophthalmol Vis Sci 39: 1227-1232.
18. Lemasters J.J., Nieminen A.L., Qian T., Trost L.C., Elmore S.P., Nishimura Y., Crowe R.A., Cascio W.E., Bradham C.A., Brenner D.A., Herman B. (1998) The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim Biophys Acta 1366: 177-196.
19. Leventhal L., Sortwell C.E., Hanbury R., Collier T.J., Kordower J.H., Palfi S. (2000) Cyclosporin A protects striatal neurons in vitro and in vivo from 3-nitropropionic acid toxicity. J Comp Neurol 425: 471-478.
20. Luchowski P., Luchowska E., Turski W.A., Urbanska E.M. (2002) 1-Methyl-4-phenylpyridinium and 3-nitropropionic acid diminish cortical synthesis of kynurenic acid via interference with kynurenine aminotransferases in rats. Neurosci Lett 330: 49-52.
21. Mattson M.P., LaFerla F.M., Chan S.L., Leissring M.A., Shepel P.N., Geiger J.D. (2000) Calcium signalling in the ER: its role in neuronal plasticity and neurodegenerative disorders. Trends Neurosci 23: 222-229.
22. Nakayama R., Yano T., Ushijima K., Abe E., Terasaki H. (2002) Effects of dantrolene on extracellular glutamate concentration and neuronal death in the rat hippocampal CA1 region subjected to transient ischemia. Anesthesiology 96: 705-710.
23. Novelli A., Reilly J.A., Lysko P.G., Henneberry R.C. (1988) Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced. Brain Res 451: 205-212.
24. Ramsay R.R., Dadgar J., Trevor A., Singer T.P. (1986) Energy-driven uptake of N-methyl-4-phenylpyridine by brain mitochondria mediates the neurotoxicity of MPTP. Life Sci 39: 581-588.
25. Rokaw M.D., West M.E., Palevsky P.M., Johnson J.P. (1996) FK-506 and rapamycin but not cyclosporin inhibit aldosterone-stimulated sodium transport in A6 cells. Am J Physiol 271: C194-C202.
26. Rusnak F., Mertz P. (2000) Calcineurin: form and function. Physiol Rev 80: 1483-1521.
27. Singleton R.H., Stone J.R., Okonkwo D.O., Pellicane A.J., Povlishock J.T. (2001) The immunophilin ligand FK506 attenuates axonal injury in an impact-acceleration model of traumatic brain injury. J Neurotrauma 18: 607-614.
28. Stone T.W. (2000) Development and therapeutic potential of kynurenic acid and kynurenine derivatives for neuroprotection. Trends Pharmacol Sci 21: 149-154.
29. Turski W.A., Gramsbergen J.B.P., Traitler H., Schwarcz R. (1989) Rat brain slices produce and liberate kynurenic acid upon exposure to L-kynurenine. J Neurochem 52: 1629-1636.
30. + seizures. Synapse 10: 120-125.
31. Uchino H., Minamikawa-Tachino R., Kristian T., Perkins G., Narazaki M., Siesjo B.K., Shibasaki F. (2002) Differential neuroprotection by cyclosporin A and FK506 following ischemia corresponds with differing abilities to inhibit calcineurin and the mitochondrial permeability transition. Neurobiol Dis 10: 219-233.
32. Urbanska E.M., Blaszczak P., Saran T., Kleinrok Z., Turski W.A. (1998) Mitochondrial toxin 3-nitropropionic acid evokes seizures in mice. Eur J Pharmacol 359: 55-58.
33. Urbanska E.M., Blaszczak P., Saran T., Kleinrok Z., Turski W.A. (1999) AMPA/kainate-related mechanisms contribute to convulsant and proconvulsant effects of 3-nitropropionic acid. Eur J Pharmacol 370: 251-256.
34. Xu L., Tripathy A., Pasek D.A., Meissner G. (1998) Potential for pharmacology of ryanodine receptor/calcium release channels. Ann N Y Acad Sci 853: 130-148.
35. Zhang L., Andou Y., Masuda S., Mitani A., Kataoka K. (1993) Dantrolene protects against ischemic, delayed neuronal death in gerbil brain. Neurosci Lett 158: 105-108.